Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: An immunohistochemical and chromogenic in situ hybridization study

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Ordás, Javier ^a   Millán, Yolanda ^a   Dios, Rafaela ^a   Reymundo, Carlos ^b   de las Mulas, Juana Martín ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b Universidad de Cordoba   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; PARAFFIN; DIAGNOSTIC AGENT; FLUORESCENT DYE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CAT; CONTROLLED STUDY; DISEASE MODEL; EMBEDDING; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PATHOLOGICAL ANATOMY; PROGNOSIS; TUMOR VOLUME; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; FEMALE; GENETICS; HUMAN; METABOLISM; PATHOLOGY; UDDER;

ANIMALS; CATS; FEMALE; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; RECEPTOR, ERBB-2;

EID: 35648950458     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-179     Document Type: Article

References (21)

1. Siegel PM Dankort DL Hardy WR Muller WJ Novel activating mutations in the neu proto - oncogene involved in induction of mammary tumors Mol Cell Biol 1994, 14:7068-7077. 359240 7935422
2. Sahin AA Biologic and clinical significance of HER-2/neu (cerbB-2) in breast cancer Adv Anat Pathol 2000, 7:158-166. 10809222
3. Ross JS Fletcher JA Bloom KJ Linnette GP Stec J Symmans WF Pusztai L Hortobagyi GN Targeted therapy in breast cancer: The HER-2/neu gene and protein Mol Cell Proteomics 2004, 3:379-398. 10.1074/mcp.R400001-MCP200 14762215
4. Tanner M Gancberg D Di Leo A Larsimont D Rouas G Paccart MJ Isola J Chromogenic in Situ Hybridization. A practical alternative for fluorescence in Situ Hybridization to detect HER-2/neu oncogene amplification in Archival Breast Cancer Samples Am J Pathol 2000, 157:1467-1472. 1885742 11073807
5. Isola J Tanner M Forsyth A Cooke TG Watters AD Bartlett JMS Interlaboratory comparison of HER-2 oncogene amplification by chromogenic and fluorescence in situ hybridization Clin Cancer Res 2004, 10:4793-4798. 10.1158/1078-0432.CCR-0428-03 15269154
6. Misdorp W Weijer K Animal model of human disease: Breast cancer Am J Pathol 1980, 98:573-576. 1903412 6986788
7. Frese K Comparative pathology of mammary tumors of domestic animals Pathology of Neoplastic and Endocrine induced diseases of the breast Stuttgart: Gustav Fischer Verlag Bäsler R, Hübner K 1986, 44-61.
8. Rutteman GR Withrow SJ MacEwen EG Tumors of the mammary gland Small Animal Clinical Oncology Philadelphia: W.B. Saunders Company Withrow SJ, MacEwen BR 2001, 455-477.
9. Millanta F Calandrella M Citi S Della Santa D Poli A Overexpression of HER-2 in feline invasive mammary carcinomas: An immunohistochemical survey and evaluation of its prognostic potential Vet Pathol 2005, 42:30-34. 10.1354/vp.42-1-30 15657269
10. Winston J Craft DM Scase TJ Bergman PJ Immunohistochemical detection of HER-2/nu expression in spontaneous feline mammary tumours VCO 2005, 3:8-15.
11. De Maria R Olivero M Iussich S Nakaichi M Murata T Biolatti B Di Renzo F Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer Cancer Res 2005, 65:907-912. 15705889
12. Ahern TE Bird RC Bird AE Wolfe LG Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines Am J Vet Res 1996, 57:693-696. 8723884
13. Rungsipipat A Tateyama S Yamaguchi R Uchida K Miyoshi N Hayashi T Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors J Vet Med Sci 1999, 61:27-32. 10.1292/jvms.61.27 10027159
14. Martín de las Mulas J Ordás J Millán Y Fernández-Soria V Ramón y Cajal S Oncogene HER-2 in canine mammary gland carcinomas: An immunohistochemical and chromogenic in situ hybridization study Breast 2003, 80:363-367.
15. Dutra AP Granja NV Schmitt FC Cassali GD c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors Braz J Med Biol Res 2005, 37:1673-1681.
16. Kott C Matz-Rensing K Kaup FJ Hercep test applied in mammary tumors in female dogs Kleintierpraxis 2005, 50:221-227.
17. Misdorp W Else RW Hellmen E Lipscomb TP Histological classification of the mammary tumors of the dog and the cat. Second series Washington, DC: AFIP 1999, VII.
18. Castagnaro M Casalone C Ru G Nervi GC Bozzeta E Caramelli M Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas J Comp Pathol 1998, 119:263-275. 10.1016/ S0021-9975(98)80049-2 9807728
19. Martín de las Mulas J van Niel M Millán Y Blakenstein MA van Mil F Misdorp W Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: Comparison with biochemical assay Domes Anim Endocrinol 2000, 18:111-125. 10.1016/ S0739-7240(99)00067-3
20. Martín de las Mulas J van Niel M Millán Y Blankenstein MA Van Mil F Misdorp W Progesterone receptors in normal, dysplastic and tumorous feline mammary glands. Comparison with oestrogen receptors status Res Vet Sci 2002, 72:153-161. 10.1053/rvsc.2001.0542 12027597
21. Slamon DJ Clark GM Wong SG Levin WJ Ullrich A McGuire WL Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 1987, 235:177-182. 10.1126/science.3798106 3798106